A Study of VEGF-Antisense Oligonucleotide in Combination With Pemetrexed and Cisplatin for the Treatment of Advanced Malignant Mesothelioma

This study has been withdrawn prior to enrollment.
(Sponsor withdrew support)
Sponsor:
Collaborator:
Sponsor Name Pending
Information provided by:
University of Southern California
ClinicalTrials.gov Identifier:
NCT00668499
First received: April 25, 2008
Last updated: January 8, 2009
Last verified: January 2009
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: April 2011
  Estimated Primary Completion Date: April 2011 (Final data collection date for primary outcome measure)